1. South Korea Stocks

  2. •

    Consumer Defensive

  3. •

    Tobacco
KT&G Corporation

KT&G Corporation

033780.KS
KT&G CorporationKR flagKorea Exchange
184,600.00
KRW
-500.00
- -
19.45TMarket Cap
KT&G Corporation
033780.KS
(Korea Exchange)

Recent

price

184,600.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
27,202.95
29,429.07
31,105.43
30,043.82
32,577.17
32,820.55
35,420.18
36,964.06
35,412.95
39,302.69
40,210.05
42,254.44
48,900.69
50,938.71
52,993.9
61,688.22
63,819.48
Revenue per Share
8,109
6,368
5,734
4,485
6,428
8,314
9,588
9,591
7,178
8,196
9,320
7,898
8,489
7,843
10,455
10,220
11,416.07
Basic EPS, GAAP
4,871.49
3,558.12
3,937.04
3,388.25
3,955.22
8,287.85
10,531.89
6,617.27
3,659.27
6,218.6
8,028.31
9,306.39
5,028.52
6,526.73
196.71
-913.64
2,359.54
Free Cash Flow per Basic Share
2,799
3,027.09
3,199.72
3,199.87
3,200
3,398.38
3,394.58
3,600.06
3,999.92
3,999.48
4,430
4,813.38
4,812.88
6,746.24
5,261.19
5,661.24
1,434.19
Dividend per Share
28,842.57
36,972.74
39,548
40,833.61
43,903.69
48,813.02
54,725.1
60,888.65
63,804.4
67,069.32
71,865.19
77,530.77
84,290.91
86,314.57
87,338.56
89,132.45
86,737.42
Book Value per Share
35,641.42
36,703.18
39,407.29
40,832.2
44,205.94
48,965.7
55,376.14
61,275.99
63,784.21
68,180.7
71,248.04
73,246.43
76,807.69
79,240.55
82,321.32
85,929.47
86,039.11
Tangible Book Value per Share
127
127
126
126
126
126
126
126
126
126
126
124
120
115
111
107
106
Basic Weighted Avg Shares
3,461,418
3,722,966
3,911,818
3,782,630
4,101,425
4,134,035
4,468,856
4,667,193
4,471,516
4,963,202
5,055,311
5,228,352
5,851,406
5,862,608
5,908,792
6,579,707
6,792,197
Sales/Revenue/Turnover
31.3
28.92
26.35
26.97
29.18
33.05
32.86
30.88
28.03
27.8
29.14
25.6
21.66
19.91
20.12
20.42
20.95
Operating Margin (%)
148,997
157,379
171,820
170,436
155,524
153,828
154,465
163,301
151,828
185,222
203,321
217,160
225,455
241,073
250,260
292,667
302,043
Depreciation Expense
1,031,823
805,593
721,108
564,678
809,277
1,047,221
1,209,689
1,210,989
906,350
1,035,003
1,171,734
977,259
1,015,785
902,662
1,165,727
1,090,072
1,214,993
Net Income, GAAP
26.67
29.71
29.15
36.72
30.21
26.84
23.39
13.42
31.69
28.97
27.32
28.86
29.07
25.54
25.14
24.2
24.89
Effective Tax Rate (%)
29.81
21.64
18.43
14.93
19.73
25.33
27.07
25.95
20.27
20.85
23.18
18.69
17.36
15.4
19.73
16.57
17.89
Profit Margin (%)
2,436,629
2,445,354
2,759,772
2,933,571
3,236,940
3,659,556
4,387,689
4,769,341
4,772,696
4,817,127
4,758,891
4,191,915
3,982,270
3,745,960
4,033,422
3,789,406
3,823,049
Working Capital
1,540
25,416
12,051
20,279
34,728
30,291
115,953
100,589
93,475
115,351
79,321
72,572
99,858
497,589
1,049,872
1,062,456
1,086,902
LT Debt
4,598,309
4,850,117
5,154,755
5,324,177
5,653,155
6,234,847
7,054,394
7,860,184
8,168,204
8,739,585
9,091,572
9,208,862
9,358,580
9,294,935
9,358,465
9,336,169
9,327,855
Total Equity
16.34
14.35
13.06
11.04
13.76
14.6
13.96
13.85
9.21
10.33
10.76
9.25
8.57
8.12
7.83
8.49
9.18
Return on Invested Capital (%)
27.57
18.7
14.56
11.01
14.86
17.24
17.85
15.98
11.17
12.19
13.12
10.45
10.44
8.74
10.87
9.95
11.58
Return on Capital (%)
28.37
19.3
14.94
11.17
15.17
17.94
18.54
16.6
11.51
12.53
13.39
10.49
10.32
9.02
11.85
11.33
13.08
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
1,129,497
780,731
664,571
LT Borrowings
1,078,120
1,030,666
1,055,869
LT Finance Leases
28,486
31,790
31,033
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
105
105
105
Market Capitalization
14,399,319
15,315,443
16,943,382

Working Capital

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
7,757,635
7,026,243
7,493,322
Cash, Cash Equivalents & STI
1,735,784
1,278,211
1,722,166
Accounts Receivable, Net
1,804,934
1,537,432
1,745,385
Inventories
3,128,734
3,284,784
3,157,759
Total Current Liabilities
4,075,006
3,236,837
3,670,273
Payables & Accruals
- -
- -
- -
ST Debt
1,129,497
780,731
664,571
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
4.22%
0.54%
-0.24%
Free Cash Flow
-60.62%
-130.04%
-544.3%
Net Income, GAAP
1.67%
-0.23%
-6.49%
Sales/Revenue/Turnover
4.89%
5.53%
11.35%
Total Cash Common Dividend
- -
3.39%
2.93%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1,292,261
1,423,774
1,636,347
1,556,410
5,908,792
2025
1,491,108
1,547,903
1,826,896
1,713,800
6,579,707
2026
1,703,598
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
2,488
2,718
2,265
- -
10,455
2025
2,370
1,328
3,898
- -
10,220
2026
3,666
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
1,271.06
- -
5,261.19
2025
- -
- -
1,393.68
- -
5,661.24
2026
18.06
- -
- -
- -
- -
Similar Companies
ITC Limited (ITC.BO)
CEA Industries Inc. Warrants (VAPEW)
British American Tobacco p.l.c. (BTAFF)
VST Industries Limited (VSTIND.BO)
Swedish Match AB (publ) (SWMA.ST)
Ispire Technology Inc. (ISPR)
Business
KT&G Corporation (KRX: 033780), a leading South Korean producer and distributor of tobacco products, health functional foods, pharmaceuticals, cosmetics, and real estate development services, operates primarily in the consumer staples sector with a focus on tobacco manufacturing, red ginseng processing, and next-generation nicotine products. Founded in 1987 and headquartered in Daejeon, South Korea, the company manufactures and sells cigarettes under flagship brands including Esse, This, The One, Bohem, and Raison; provides reconstituted tobacco sheets and leaf tobacco cultivation support; offers red ginseng extracts, red ginseng products, other health foods, food and beverage items, and health functional foods under the KGC brand; develops and distributes prescription drugs, bio-pharmaceuticals, over-the-counter medicines, antibiotics, medical supplies, and equipment; produces cosmetics and related personal care items; and engages in real estate trading, leasing, housing development, and hotel management through properties like Sangsang Madang and Sangsang Stay. KT&G maintains global operations across South Korea, Europe, Russia, Turkey, Indonesia, Kazakhstan, Taiwan, the Middle East, North Africa, Latin America, Asia-Pacific, and 148 export countries, generating the majority of revenue from its tobacco segment supplemented by health functional foods, pharmaceuticals, and real estate. In recent developments, KT&G formed a strategic partnership with U.S. tobacco giant Altria in September 2025 through a memorandum of understanding covering nicotine and non-nicotine businesses, including the joint acquisition of Sweden-based Another Snus Factory, producer of the LOOP nicotine pouch brand, to expand into the fast-growing nicotine pouch market with U.S. distribution access and entry into Nordic, European, Middle East, and other regions starting 2026; invested $450 million by 2026 to build two new factories in Indonesia as an export hub for Asia-Pacific and Middle East markets while expanding its Turkish facility by 1.5 times with $60 million for North Africa and Latin America; launched its global superslim cigarette brand Esse in Germany in July 2025 for full-scale European entry; introduced the upgraded lil Hybrid 4.0 heated tobacco and vape device with expanded e-liquid capacity alongside plans for vape category diversification; established a subsidiary in Kazakhstan in 2023 and explored modern nicotine product opportunities via partnerships, in-house development, and acquisitions; and announced enhanced shareholder returns including a 6,000 KRW annual dividend per share and share buybacks amid strong global growth, with overseas next-generation product revenue nearly doubling and Q3 2025 net profit up 73% year-over-year.